Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2005
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596104A Modified release dosage forms
03/16/2005CN1596102A Regulation dosage forms
03/16/2005CN1596101A Fondant composition contained dosage forms
03/16/2005CN1596100A Edible composition and dosage form comprising an edible shell
03/16/2005CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants)
03/16/2005CN1594308A Tectoridin isoflavone derivatives, their preparation process, and anti-virus medicines with tectoridin isoflavone derivatives as active components
03/16/2005CN1593625A Orally disintegrating tablet of throat clearing medicine and its preparation process
03/16/2005CN1593622A Orally disintegrating tablet of 'Shuanghuanglian' and its preparation
03/16/2005CN1593619A Detoxification Chinese medicine
03/16/2005CN1593595A Lung clearing preparation for treating respiratory virus infection diseases
03/16/2005CN1593594A Chinese traditional medicinal composition and its preparation process and usage
03/16/2005CN1593587A Lung nourishing and regulating pills for the lung pattern disease and its preparation method
03/16/2005CN1593560A Chinese medicinal prescription for treating chronic bronchitis
03/16/2005CN1593558A Sarcandra extract and its application
03/16/2005CN1593554A Medicine for treating diseases of respiratory system
03/16/2005CN1593525A Throat ache relieving medicine
03/16/2005CN1593513A Dripping pills of 'Zhenkening' for stopping cough and its preparing process
03/16/2005CN1593487A Compound buccal lozenge of licorice and its preparing process
03/16/2005CN1593449A self emulsifying soft capsule of breviscapine and its preparation
03/16/2005CN1593429A Novel oral guacetisal solid preparation and its preparing method
03/16/2005CN1593414A Powder inhalation of tiotropium bromide capsule type and its preparation method
03/16/2005CN1593413A Sustained release compound capsules and its preparation method
03/16/2005CN1193029C New 7-amino pyrido[2, 3-d] pyrimidine derivative, its composition and use
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
03/16/2005CN1192798C Vaccine
03/16/2005CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV)
03/16/2005CN1192792C Chinese medicine for treating chronic obstructive lung disease
03/16/2005CN1192791C Cold preventing Chinese medicine powder and its preparation method
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/15/2005US6867313 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
03/15/2005US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/10/2005WO2005021548A2 Substituted 8-heteroaryl xanthines
03/10/2005WO2005021518A1 Condensed ring compound and use thereof
03/10/2005WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
03/10/2005WO2005021037A1 Composition comprising a pulmonary surfactant and a pde2 inhibitor
03/10/2005WO2004105731A8 Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054719 Dimeric compounds and their use as anti-viral agents
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054664 Anticholinergics, processes for preparing them and pharmaceutical composition containing them
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054593 New drug
03/10/2005US20050054588 Methods and compositions for the treatment of asthma and related disorders
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053659 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
03/10/2005US20050053654 able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt and a binder, in the form of a coated granule, and excipients such as disintegrating agent, a soluble diluent, and a lubricant
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053553 Combined doses of formoterol and fluticasone
03/10/2005CA2536553A1 Substituted 8-heteroaryl xanthines
03/10/2005CA2536458A1 Composition comprising a pulmonary surfactant and a pde2 inhibitor
03/10/2005CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511512A1 Novel uses of parapoxvirus preparations
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511500A2 Combination of anti-muscarinic agents and non-glucocorticoid steroids
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511466A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
03/09/2005EP1307440B1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
03/09/2005EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors